Presentation JIM 2020

Long term antithrombotic therapy in high risk PCI: Consider low-dose rivaroxaban with SAPT

Presenter: Giuseppe Tarantini

February 13, 2020

REGISTER for free or LOG IN to view this content

Long term antithrombotic therapy in high risk PCI: Consider low-dose rivaroxaban with SAPT

Coronary

JIM 2020

Antithrombotic

PCI

Rivaroxaban

Up Next

Presentation JIM 2020

Long-term antithrombotic therapy in high-risk PCI patients

Presenter: Alberto Menozzi

February 13, 2020

More slides +

Presentation JIM 2020

Optimal LDL levels in patients with ACS undergoing PCI

Presenter: Giuseppe Musumeci

February 13, 2020

Presentation JIM 2020

Ultra LOW LDL is the target for high risk patients

Presenter: Francesco Prati

February 13, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.